IMMURON
Who is IMMURON?
Immuron Ltd (ASX:IMC) (NASDAQ:IMRN) is an Australian based and globally integrated biopharmaceutical company that has developed two commercially available oral immunotherapeutic products for the treatment of gut mediated diseases. ACCEPTABLE USE POLICY We welcome your comments on our page but we as...See more
Industry & Specialities
Others
Countries of Operation
Australia
Headquarters:
Australia
Company Type:
MNC / Large Enterprise
Company size:
11-50 Employees
Address:
SUITE 10- 25 CHAPMAN STREET; BLACKBURN NORTH; MELBOURNE, VICTORIA 3130, AU
Employees by Department
- Sales (2)
- The Rest (7)
- Total (9)
Key Decision Makers
Kerry Mcveigh
Office Managert
Joanne Casey
R&D Manager
Peter Mccann
National Manager Clinical Eduation
Flavio Palumbo
Chief Commercial Officer
Employees by Seniority
C-level
3employees
Senior
0employees
Non-managers
2employees
Financials
LOW
spending power
Funding Status
Publicly listed on stock exchange
Associated Legal Entities
0 entities
Discover More Companies
Lookalike companies
Featured Lists
- SMEs in Singapore
- MNCs / Large Enterprises in Singapore
Frequently Asked Questions (FAQ)
- What is the funding status of IMMURON?
- Where is IMMURON's headquarter?
- What IMMURON's spending power?
- Does IMMURON have a presence in the domain it operates in?